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This issue of Frontiers in Physiology presents a collection
of manuscripts including original research and comprehensive
reviews that examine the effects of second hand smoke (SHS)
on the development and progression of chronic obstructive pul-
monary disease (COPD). The health effects and costs of SHS are a
burgeoning concern as it is estimated that more than 126 million
people in the United States are exposed to SHS (Menzies, 2011).
Although there is a decrease of smokers in the US, the economic
aspects of SHS exposure is substantial and often occurs not only
at the workplace, but also at personal homes (Max et al., 2012).
As described in the accompanying manuscripts, SHS has been
associated with an increased risk of cardiovascular disease, sev-
eral cancers, stroke, and type 2 diabetes mellitus. Several studies
have shown associations between SHS and sudden infant death
syndrome, acute respiratory infections, ear infections, and the
development of asthma in infants and children. SHS can also
contribute to the development of COPD in non-smokers and
exacerbate COPD pathogenesis in smokers. Unfortunately, rela-
tively little is known about the cellular andmolecularmechanisms
whereby SHS contributes to these diseases including COPD and
as a result, insight from animal models can be challenging to
translate properly into the human disease. The purpose of this
collection is to present the newest data and updated reviews on
the role of SHS in the pathogenesis of COPD with a focus on
mechanistic studies performed in animal models.
The original research articles presented in this collection
examine the influence of dietary vitamin D levels on the sus-
ceptibility to SHS-induced pathology, the effects of SHS in a
model of pre-existing pulmonary inflammation induced by the
genetic deletion of a key leukocyte signaling molecule (Arhgef1),
and the role of STAT3 (a master transcriptional regulator of pro-
inflammatory genes) in the control of inflammation and protease
expression in the lung. In the report by Crane-Godreau et al.
(2013), the authors utilized a novel mouse model of dietary vita-
min D deficiency and SHS exposure to examine the hypothesis
that low vitamin D levels contribute to the lower lung func-
tion and disease severity in response to cigarette smoke exposure.
These studies revealed that vitamin D deficiency exacerbates the
alveolar tissue destruction compared to mice receiving a vitamin
D supplemented diet following 16 weeks of daily SHS exposure.
Furthermore, the authors provide evidence of a significant shift
in the protease-antiprotease balance as a consequence of vitamin
D depletion that provides mechanistic insight into the pathways
affected by vitamin D deficiency. This work establishes a useful
model to further study the effects of dietary vitamin D and the
development of pulmonary pathology in response to SHS. The
work of Harney et al. also utilizes a novel model to examine the
effects of sub-chronic SHS exposure on pulmonary inflammation
and tissue destruction (Hartney et al., 2012). Utilizing a mouse
genetically deficient in the leukocyte signaling molecule Arhgef,
the authors were able to demonstrate that SHS has the capacity
to significantly enhance underlying pulmonary inflammation and
tissue destruction. Importantly, the data revealed that the effects
of the SHS were independent of the baseline inflammation in the
mutant mouse model. Therefore, this model is extremely useful
for extrapolating and defining the mechanisms of SHS-enhanced
pathogenesis in the context of pulmonary inflammation unre-
lated to smoke exposure. Lastly, Geraghty et al. utilize a mouse
model deficient in STAT3 to demonstrate the importance of this
critical signaling pathway in the pulmonary response to SHS
(Geraghty et al., 2013). The authors showed that tobacco smoke
activates STAT3—mediated inflammation, proteolysis, and apop-
totic responses in the lung. They further provide a link between
the activation of STAT3 and the inhibition of pathways that
modulate the anti-inflammatory pathways in the lung.
In addition to the original reports, this issue also presents
focused reviews on the effects of SHS on airway secretions and
mucociliary clearance (Liu and Di, 2012), the generation and
physiological consequences of smoke-induced advanced glycation
end-products (Robinson et al., 2012), and the current factors
that have been reported in animal models to influence SHS-
induced COPD pathologies (Birru and Di, 2012). Finally, the
issue presents two comprehensive reviews that detail current
understanding of the effects of SHS on lung pathogenesis that has
been defined by utilizing animal models, which is a challenging
aspect as different rodents develop emphysema at different time
points. Goldklang et al. provide a provocative and informative
discussion of the lessons learned from animal models of smoke
exposure including the strengths and weaknesses of the various
models (Goldklang et al., 2013). The Taraseviciene-Stewart lab
rounds off the issue with the most current and comprehensive
review to date of the effects of tobacco smoke induced pathology
described in animal models (Leberl et al., 2013). This review thor-
oughly summarizes the results of 155 studies addressing cigarette
smoke exposure in animal models. Parameters including, species,
strain, exposure methodologies, exposure duration and dose,
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endpoint descriptors, and summaries of the results are thoroughly
presented in tables and in discussion formats. In addition to the
most common endpoints described in smoke-induced patholo-
gies, this review expands the possibilities and current knowledge
of the usefulness of animal studies to investigate small airway
remodeling and pulmonary hypertension.
Together, these reports provide insight into the usefulness of
animal models of SHS exposure to define potential mechanisms
of action in pulmonary pathology as well as timely, thorough
updates on our current understanding of the pathologic effects of
SHS. Given the tremendous numbers of persons exposed unwill-
ingly to SHS and the likelihood of an increase in COPD in the
coming years, it is imperative that the health effects associated
with these exposures are carefully and fully examined. The use
of animal models for such studies is necessary and, therefore, it is
important that the strengths, limitations and relevance to human
disease be explored and discussed.
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